AnalystsYi ChenYi Chen's Stock Forecasts
AnalystsYi Chen
Analyst Ranking
Bottom 1%
#4858 out of 4868 analysts
Average Return
-7.68%
Win Rate
32%171 out of 542
Risk vs Reward
Poor
Good
Yi Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Htg Molecular Diagnostics IncHTGMQ | +1,622.56% | $59.04 | $67.80 | 2020-03-25 - 2021-03-26 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +758.90% | $3.26 | $28.00 | 2023-03-02 - 2024-03-01 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +728.74% | $3.34 | $27.68 | 2023-02-27 - 2024-02-28 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +628.98% | $2.83 | $20.63 | 2023-03-26 - 2024-03-26 | Buy |
Sensus Healthcare IncSRTS | +301.93% | $3.62 | $14.55 | 2021-08-05 - 2022-08-05 | Buy |
Yi Chen Analyst Color
Get additional color on Yi Chen's coverage of popular stocks
Yi Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zynex IncZYXI | 21 | Buy | $8.00 | +381.93% | Maintains | a day ago |
Lifemd IncLFMD | 9 | Buy | $14.00 | +90.22% | Reiterates | a day ago |
Alpha Tau Medical LtdDRTS | 18 | Buy | $9.00 | +251.56% | Reiterates | 2 days ago |
Greenwich Lifesciences IncGLSI | 8 | Buy | $39.00 | +286.14% | Maintains | 10 days ago |
Oculis Holding AgOCS | 14 | Buy | $32.00 | +83.91% | Maintains | 14 days ago |
Vivani Medical IncVANI | 5 | Buy | $4.00 | +288.35% | Reiterates | 15 days ago |
Volitionrx LtdVNRX | 2 | Buy | $2.50 | +420.83% | Reiterates | 20 days ago |
Bionano Genomics IncBNGO | 1 | Buy | $10.00 | +150.63% | Initiates Coverage On | 22 days ago |
Opko Health IncOPK | 14 | Buy | $3.00 | +117.39% | Reiterates | 24 days ago |
Angiodynamics IncANGO | 10 | Buy | $16.00 | +72.23% | Maintains | 24 days ago |
Sensus Healthcare IncSRTS | 16 | Buy | $12.00 | +179.07% | Reiterates | a month ago |
Orchestra Biomed Holdings IncOBIO | 4 | Buy | $12.00 | +304.04% | Maintains | a month ago |
Kala Bio IncKALA | 21 | Buy | $15.00 | +277.83% | Reiterates | a month ago |
Clearside Biomedical IncCLSD | 20 | Buy | $6.00 | +593.64% | Reiterates | a month ago |
Virax Biolabs Group LtdVRAX | 1 | Buy | $3.00 | +206.12% | Initiates Coverage On | a month ago |
Harrow IncHROW | 3 | Buy | $57.00 | +130.12% | Reiterates | a month ago |
Co Diagnostics IncCODX | 17 | Hold | $1.00 | +184.90% | Maintains | a month ago |
Icecure Medical LtdICCM | 20 | Buy | $2.50 | +98.41% | Reiterates | a month ago |
Kiora Pharmaceuticals IncKPRX | 15 | Buy | $10.00 | +210.56% | Reiterates | a month ago |
Sanara Medtech IncSMTI | 3 | Buy | $51.00 | +59.67% | Maintains | a month ago |
Anixa Biosciences IncANIX | 19 | Buy | $7.00 | +150.90% | Reiterates | a month ago |
Barinthus Biotherapeutics PLCBRNS | 20 | Buy | $3.00 | +167.86% | Reiterates | a month ago |
Regenxbio IncRGNX | 10 | Buy | $34.00 | +253.80% | Reiterates | a month ago |
Belite Bio IncBLTE | 18 | Buy | $100.00 | +62.65% | Reiterates | a month ago |
Tourmaline Bio IncTRML | 6 | Buy | $50.00 | +190.53% | Maintains | 2 months ago |
Eyepoint Pharmaceuticals IncEYPT | 21 | Buy | $22.00 | +222.58% | Reiterates | 2 months ago |
Biolife Solutions IncBLFS | 1 | Buy | $30.00 | +24.43% | Maintains | 2 months ago |
Ocular Therapeutix IncOCUL | 22 | Buy | $15.00 | +80.72% | Reiterates | 2 months ago |
Caredx IncCDNA | 3 | Hold | $25.00 | +48.10% | Maintains | 2 months ago |
Bausch & Lomb CorpBLCO | 17 | Buy | $20.00 | +73.01% | Maintains | 2 months ago |
Okyo Pharma LtdOKYO | 12 | Buy | $7.00 | +341.64% | Reiterates | 2 months ago |
Lexaria Bioscience CorpLEXX | 5 | Buy | $7.00 | +503.45% | Maintains | 3 months ago |
Veru IncVERU | 18 | Buy | $3.00 | +453.51% | Reiterates | 4 months ago |
Renalytix PLCRNLXY | 9 | Buy | $3.00 | +1,349.28% | Reiterates | 10 months ago |
Alimera Sciences IncALIM | 16 | Hold | $6.00 | +8.30% | Downgrades | 10 months ago |
Applied Dna Sciences IncAPDN | 16 | Buy | $75.00 | +8,393.77% | Maintains | a year ago |
Genprex IncGNPX | 4 | Buy | $10.00 | +3,348.28% | Reiterates | a year ago |
Aslan Pharmaceuticals LtdASLN | 19 | Buy | $72.00 | +11,900.00% | Reiterates | a year ago |
Mainz Biomed NvMYNZ | 9 | Buy | $120.00 | N/A | Maintains | a year ago |
Prophase Labs IncPRPH | 14 | Buy | $11.00 | N/A | Reiterates | a year ago |
Motus Gi Holdings IncMOTS | 8 | Buy | $37.50 | N/A | Reiterates | 2 years ago |
Nemaura Medical IncNMRD | 4 | Buy | $2.50 | N/A | Maintains | 2 years ago |
Opgen IncOPGN | 5 | Buy | $30.00 | N/A | Reiterates | 2 years ago |
Entero Therapeutics IncENTO | 13 | Buy | $200.00 | N/A | Reiterates | 2 years ago |
Centogene NvCNTGF | 8 | Buy | $1.50 | N/A | Reiterates | 2 years ago |
Check Cap LtdCHEK | 6 | Buy | $7.00 | N/A | Reiterates | 2 years ago |
Htg Molecular Diagnostics IncHTGMQ | 10 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Meridian Bioscience IncVIVO | 7 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Stealth Biotherapeutics CorpMITO | 3 | Buy | $1.50 | N/A | Maintains | 3 years ago |
Bio Path Holdings IncBPTH | 1 | Buy | $180.00 | N/A | Maintains | 3 years ago |
Dentsply Sirona IncXRAY | 5 | Hold | $48.00 | N/A | Maintains | 3 years ago |
Ortho Clinical Diagnostics Holdings PLCOCDX | 3 | Hold | $24.68 | N/A | Downgrades | 3 years ago |
Interpace Biosciences IncIDXG | 3 | Buy | $9.00 | N/A | Maintains | 4 years ago |
Eyenovia IncEYEN | 5 | Buy | $640.00 | N/A | Maintains | 4 years ago |
Celcuity IncCELC | 2 | Buy | $19.00 | N/A | Maintains | 4 years ago |
Cytodyn IncCYDY | 2 | Buy | $4.00 | N/A | Reiterates | 5 years ago |
Oragenics IncOGEN | 1 | Buy | $120.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.